united therapeutics glp-1 receptor agonist agonists Evolution of GLP‐1 Receptor Agonists
Description
Due to supply and funding constraints, most UK patients cannot access semaglutide 2.4 mg, even in specialist services
70 Patients who proactively follow dietary changes may require greater dose reductions of sulphonylureas or insulin to avoid hypoglycaemia
Each receptor of this family is concisely named based on its single and unique endogenous ligand (GLP-1R, GLP-2R, GCGR, GIPR, SCTR, and GHRHR)
10.1210/endocr/bqad153 50 MaoT.ZhangC.YangS.BiY.LiM.YuJ
